(Q43719489)

26 November 2017

title

Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease (English)

1 reference

polycystic ovary syndrome

26 November 2017

main subject

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

1 reference

Sabuncu T

1

1 reference

26 November 2017

Vural H

series ordinal

2

1 reference

26 November 2017

Harma M

series ordinal

3

1 reference

26 November 2017

Harma M

series ordinal

4

1 reference

26 November 2017

publication date

1 July 2001

1 reference

26 November 2017

published in

Clinical Biochemistry

1 reference

26 November 2017

volume

34

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

407-413

1 reference

Polycystic ovary syndrome

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Obesity, lipids, cardiovascular risk, and androgen excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Clinical signs of androgen excess as risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Oxygen-derived free radicals in postischemic tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

The oxygen free radical system: potential mediator of myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Role of oxygen free radicals in ischemic and reperfused myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxidation and protective enzymes during myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Free radical pathology in chronic arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Free-radical oxidation and antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovarian disease: US features in 104 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis Risk in Communities Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Antioxidant enzyme alterations in experimental and clinical diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Racial differences in the relation between blood pressure and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Normal serum uric acid concentrations in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Serum antioxidant status in streptozotocin-induced diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

10.1016/S0009-9120(01)00245-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference